Not All PDE4 Inhibitors Are the Same
Patrick Burnett, MD, PhD, FAAD
PASI-HD: New Method for Measuring Severity in Mild to Moderate Plaque Psoriasis
Robert Higham, MPAS, PA-C
Current Unmet Needs in Plaque Psoriasis
Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer
Meaningful Innovation in Medical Dermatology at Arcutis Biotherapeutics
Frank Watanabe, CEO
Loading...
We're glad to see you're enjoying PracticalDermatology… but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.